Effects and side-effects of bromperidol in comparison with other antipsychotic drugs

Area of Science:

• Psychiatry and Pharmacology

Background:

• Schizophrenia is a complex mental disorder characterized by psychotic symptoms and often accompanied by depressive symptoms.
• Antipsychotic medications are the cornerstone of schizophrenia treatment, with various agents exhibiting different efficacy and side-effect profiles.

Purpose of the Study:

• To evaluate the efficacy and tolerability of bromperidol in hospitalized patients with schizophrenia.
• To compare the effects of bromperidol with clozapine and haloperidol in open trials.
• To assess the antipsychotic efficacy and onset of action of bromperidol versus perphenazine in a double-blind study.

Main Methods:

• An open-label trial involving 25 hospitalized schizophrenic patients treated with bromperidol for up to 30 days, with dosage adjusted up to 5 mg/day.
• Utilized the AMP system for registering effects and side-effects.
• Compared data with existing open trials of clozapine and haloperidol; conducted a double-blind comparison of bromperidol and perphenazine in 40 patients.

Main Results:

• Bromperidol demonstrated significant efficacy in treating productive schizophrenic symptoms and notably reduced accompanying depressive symptoms.
• Comparison with clozapine and haloperidol revealed similar effects on psychotic symptoms but varying severity of extrapyramidal side-effects.
• The double-blind trial showed strong antipsychotic efficacy for bromperidol and an earlier onset of therapeutic effects compared to perphenazine.

Conclusions:

• Bromperidol is an effective antipsychotic agent for schizophrenia, offering benefits for both positive symptoms and depressive comorbidities.
• Bromperidol exhibits a favorable efficacy profile with potentially fewer extrapyramidal side-effects compared to some other antipsychotics.
• The drug's rapid onset of action suggests it may be a valuable option for acute management of schizophrenic episodes.